6C42.6  Synthetic cannabinoid -induced psychotic disorder  


Synthetic cannabinoid -induced delirium is characterised by an acute state of 
disturbed attention and awareness with specific features of delirium that develops 
during or soon after substance intoxication or withdrawal  or during the use of 
synthetic cannabinoids. The amount and duration of synthetic cannabinoid use must 
be capable of producing delirium. The symptoms are not better explained by a 
primary mental disorder, by use of or withdrawal from a different substance , or by 
another health condition that is not classified under Mental, behavioural and 
neurodevelopmental disorders.  
Coding Note:  Code also the causing condition  
 470  ICD-11 MMS  
 